Recordati Industria Chimica e Farmaceutica S.p.A.
RCDTF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 1.28 | -1.13 | 0.35 | -1.15 |
| FCF Yield | 1.19% | 0.64% | 1.48% | -6.32% |
| EV / EBITDA | 51.81 | 57.53 | 42.43 | 62.40 |
| Quality | ||||
| ROIC | 2.75% | 2.46% | 3.53% | 2.36% |
| Gross Margin | 68.38% | 65.83% | 67.47% | 69.07% |
| Cash Conversion Ratio | 1.38 | 1.18 | 1.32 | 1.48 |
| Growth | ||||
| Revenue 3-Year CAGR | 7.93% | 7.34% | 6.73% | 8.11% |
| Free Cash Flow Growth | 88.69% | -53.38% | 122.36% | -509.32% |
| Safety | ||||
| Net Debt / EBITDA | -0.65 | -1.34 | -1.29 | -1.74 |
| Interest Coverage | 7.13 | 5.54 | 7.40 | 6.22 |
| Efficiency | ||||
| Inventory Turnover | 0.40 | 0.45 | 0.45 | 0.37 |
| Cash Conversion Cycle | 185.20 | 164.72 | 156.05 | 183.69 |